Author(s): Karberg S
Abstract Share this page
Abstract Reversible epigenetic changes that alter gene expression are a characteristic of many cancers and other diseases. Biotech companies are taking note and are starting to develop new drugs to reverse such pathogenic "epimutations."
This article was published in Cell
and referenced in Journal of Clinical & Cellular Immunology